TY - JOUR
T1 - Autonomic function testing in the COVID-19 pandemic
T2 - an American Autonomic Society position statement
AU - the American Autonomic Society
AU - Figueroa, Juan J.
AU - Cheshire, William P.
AU - Claydon, Victoria E.
AU - Norcliffe-Kaufmann, Lucy
AU - Peltier, Amanda
AU - Singer, Wolfgang
AU - Snapper, Howard
AU - Vernino, Steven
AU - Raj, Satish R.
N1 - Funding Information:
JJF – None. WPC – None. VEC – Research grants from the Heart and Stroke Foundation of Canada, Craig H Nielsen Foundation, and International Collaboration On Repair Discoveries. LNK – None. AP – None. WS – None. HS – None. SV – SV has received research support from Dysautonomia International, Genentech, Grifols, Rex Griswold Foundation, and Athena/Quest Diagnostics and personal compensation for consulting for Argenx, Alexion, and Lundbeck. SV has provided medicolegal consultation related to HPV vaccination. SRR – SRR has grant support from the Canadian Institutes of Health Research (Ottawa, Canada), Cardiac Arrhythmia Network of Canada (London, ON, Canada), and Dysautonomia International (East Moriches, NY, USA). SRR is a consultant for Lundbeck LLC and Theravance Biopharma, and serves as DSMB Chair for a phase 2 study run by Arena Pharmaceuticals. SRR has received compensation for editorial activities (Associate Editor) with Autonomic Neuroscience: Basic and Clinical.
Funding Information:
This work was supported in part by the National Institutes of Health grant UL1 TR000445, and by the Canadian Institutes of Health Research (CIHR; Ottawa, Canada) grant MOP142426.
Publisher Copyright:
© 2020, Springer-Verlag GmbH Germany, part of Springer Nature.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/8/1
Y1 - 2020/8/1
N2 - COVID-19 is a global pandemic that is wreaking havoc with the health and economy of much of human civilization. In this document from the American Autonomic Society, we identify the potential risks of exposure to patients, physicians, and allied healthcare staff. We provide guidance for conducting autonomic function testing safely in this environment.
AB - COVID-19 is a global pandemic that is wreaking havoc with the health and economy of much of human civilization. In this document from the American Autonomic Society, we identify the potential risks of exposure to patients, physicians, and allied healthcare staff. We provide guidance for conducting autonomic function testing safely in this environment.
UR - http://www.scopus.com/inward/record.url?scp=85086398928&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086398928&partnerID=8YFLogxK
U2 - 10.1007/s10286-020-00702-4
DO - 10.1007/s10286-020-00702-4
M3 - Review article
C2 - 32529405
AN - SCOPUS:85086398928
VL - 30
SP - 295
EP - 297
JO - Clinical Autonomic Research
JF - Clinical Autonomic Research
SN - 0959-9851
IS - 4
ER -